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Case Report

Successful management of hypoadrenocorticism in a French
Bulldog by a smaller dose and lesser frequency of the
desoxycorticosterone pivalate: a case report

Phuttipan Channgam1 Walasinee Sakcamduang1*

Abstract
A 1 year and 4 months old, intact female French Bulldog was presented because of weakness, anorexia, and
vomiting for 3 days. Laboratory findings included azotemia, hyponatremia, hypochloremia, sodium to potassium
(Na:K) ratio was 23.88, and the lower level of basal cortisol concentration than the detection limit. The small size of both
adrenal glands obtained from abdominal ultrasonography. Subsequently, the adrenocorticotropic hormone (ACTH)
stimulation test was performed, and the diagnosis of hypoadrenocorticism was confirmed. The desoxycorticosterone
pivalate (DOCP) with a smaller dose and lesser frequency than the recommendation of 2.2 mg/kg every 25 days. The
dog received DOCP subcutaneous injection at a dose of 1.5 mg/kg initially and followed by 1.37 mg/kg 55 days after
the first injection, 1.37 mg/kg 28 days after the second injection, and more than 84 days after a dose of 1.37 mg/kg of
the third injection. Glucocorticoid administrations were in recommended doses for the whole period of management.
Improvement of clinical manifestations and laboratory parameters of the dog was observed a week later after the DOCP
intervention. A smaller than recommended dose and lesser frequency of the DOCP with prednisolone seems adequate
for controlling clinical problems in the successful management of the hypoadrenocorticism in a French Bulldog.
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Introduction
Hypoadrenocorticism (Addison’s disease) is
commonly mistaken for other conditions from the
vague and nonspecific clinical signs attributable to its
multiple systems involvement. This can lead to timeconsuming, financial and emotional stress. A successful
diagnosis solves a medical mystery, saves a sick animal
and addresses a promising prognosis. Spontaneous
recovery has not been reported (Scott-Moncrieff, 2015).
The prevalence in dogs has been approximated at
0.3% to 1.1%, of which the typical age is between 2 and 6
years (Bellumori et al.., 2013). As in humans, females
(bitches) represent a higher proportion than male dogs.
The predisposed breeds are the Portuguese Waterdog,
the Standard Poodle, the Nova Scotia Duck Tolling
Retriever and the Bearded Collie, which have inherited
an autosomal recessive trait (Scott-Moncrieff, 2015).
Hypoadrenocorticism has a variety of clinical
manifestations and diagnostic findings that imitate
other diseases. The typical electrolyte changes of
hyperkalemia and hyponatremia with a low sodium
and potassium ratio combined with a low lymphocyte
count have led to suspicions of the illness. An
adrenocorticotropic hormone (ACTH) stimulation test
is required for a definitive diagnosis (Seth et al., 2011).
Treatment of hypoadrenocorticism consists of
glucocorticoid, prednisolone and mineralocorticoid;
and either desoxycorticosterone pivalate (DOCP) or
fludrocortisone supplementation. The difference in
DOCP that it is a long-acting mineralocorticoid without
the composition of glucocorticoid, instead of
fludrocortisone containing both supplementations
(Scott-Moncrieff, 2015).
This case study was reported because the dog
presented with no improvement palliative treatment
by a local veterinary practice as the dog had nonspecific clinical manifestations and was a nonTable 1

predisposing breed. The logical approach was
conducted for a definitive diagnosis. Monitoring
clinical signs and electrolytes guided dose and
frequency of medical treatment.

Materials and Methods
Signalment & History: A 1 year 4 months old, intact
female French Bulldog was presented at Prasu-Arthorn
Animal Hospital, Mahidol University, Thailand,
because of exhibiting weakness, anorexia and vomiting
for three days. It had previously been prescribed
marbofloxacin, sucralfate and fluid therapy from a
local clinic for three days without improvement. The
dog was up to date in vaccination, heartworm
prophylaxis and tick prevention.
Physical examination: The dog was depressed. Its
rectal temperature was normal at 101.4 ºF; the heart rate
was 128 beats per minute with a normal heart sound;
the respiratory rate was 28 breaths per minute with a
normal lung sound, pink mucous membranes and a
capillary refill time (CRT) of less than 2 seconds. Its
body weight was 13.9 kg and the body condition score
was 5/9. The dog did not show any abnormality from
abdominal palpation. The systolic blood pressure was
160 mmHg.
Diagnostic plan, initial treatment plan and outcome:
The dog was admitted for diagnosis, treatment and
monitoring. Blood was collected for a complete blood
count (CBC), serum biochemistry and electrolyte
profiles. Urine was also collected by cystocentesis for
urinalysis. Abnormalities included polycythemia,
azotemia,
hyperproteinemia,
hyponatremia,
hypochloremia and the Na:K ratio was 23.9:1 (Table 1).
Urinalysis showed urine specific gravity at 1.030, pH
6.0 and no other abnormalities were detected.

Hematology, serum biochemistry, and serum electrolyte values measured before admission (day 0).

Parameters

Values

Red blood cell

8.65

Hemoglobin
Hematocrit
MCV
MCH
MCHC
Platelets

20.6
61
70.5
23.8
33.8
236

Plasma protein
RDW

9
13
11.65

White blood cell count
Monocyte

0.93

Neutrophil

8.5

Lymphocyte

2.1

Eosinophil

0.12

References
6

5.0-9.0 × 10 /μL
10-18 g/dL
35-55%
60-77 fL
20-25 pg
32-36 g/dL
3

200-500 × 10 /μL
6.0-7.5
12-15%
3

6.0-17.0 × 10 /μL
3

0.2-1.7 × 10 /μL
3

3.6-13.1 × 10 /μL

Parameters

Values

References

Alkaline phosphatase

30

23-212 U/L

Alanine aminotransferase
Blood urea nitrogen (BUN)
Creatinine
Albumin
Total protein
Potassium (K)

41
59
2.55
3.7
7.2
5.34

10-100 U/L
7-27 mg/dL
0.5-1.8 mg/dL
2.7-3.8 g/dL
5.2-8.2 g/dL
3.5-5.8 mmol/L

Sodium (Na)
Chloride (Cl)
Carbondioxide (CO2)

127.5
94.6
17

142-152 mmol/L
109-122 mmol/L
18-29 mmol/L

Sodium to potassium ratio

23.88

27:1 – 40:1

Canine pancreatic lipase

< 50

0-199 ng/mL

3

0.7-5.1 × 10 /μL
3

0.1-1.7 × 10 /μL
MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; RDW,
red blood cell distribution width.
References obtained from the Laboratory unit, Prasu-arthorn Animal Hospital, Faculty of Veterinary Science, Mahidol University.
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The dog was catheterized intravenously (IV) for
normal saline (0.9% NSS) infusion at 4.61 ml/kg/h for the
first 24 hours, omeprazole (0.5 mg/kg IV q 12 h) and
ondansetron (0.5 mg/kg IV q 24 h). Urine output was
also monitored and yielded 1.8 ml/kg/h for the first 4
hours.
In the first 24 hours, the dog improved with no
clinical abnormalities. The azotemia was resolved but
there was no improvement in the hyponatremia or
hypochloremia. The Na:K ratio was 23.4:1. It was
measured for basal cortisol concentration and <0.23
µg% was found, less than the normal reference range.
Abdominal ultrasonography was performed and
showed no abdominal organ abnormalities, except for
a smaller size of both adrenal glands. The dog was
discharged on day 3.
It underwent an ACTH stimulation test 4 days later
(day 7) and cortisol levels <0.23 μg% before and one hour
after the intravenous injection of 63 μg (dose 5 μg/kg) of
compounded tetracosactide acetate (Synacthen®) were
found. Pre-and post-ACTH cortisol concentrations less
than the reference range for basal cortisol (2 μg%)
confirmed the diagnosis of hypoadrenocorticism
(Scott-Moncrieff, 2015).

Figure 1
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Long term management, monitoring and outcome: The
dog was injected with desoxycorticosterone pivalate
(DOCP, Zycortal, Dechra) 1.5 mg/kg SC on day 14 after
the first visit. It was discharged with only prednisolone
0.5 mg/kg PO q 12 h. It re-visited 7 days later without
vomiting or diarrhea. It was given tapered
prednisolone to 0.76 mg/kg PO q 24 h on day 19 and
was scheduled to revisit every 2 weeks for monitoring
following the DOCP intervention. Serum Na:K ratio
and potassium concentration were the major
information for the next DOCP intervention. If the Na:K
ratio were less than 30 and potassium concentration
were in the normal range, the DOCP injection would
have worked. After monitoring the results, the dog was
injected DOCP at a dose of 1.37 mg/kg on day 69, and
day 97, whereas the dosage of prednisolone had been
0.57 mg/kg PO q 24 on day 26, 0.38 mg/kg q 24 h on day
69 and 0.18 mg/kg PO q 24 h since day 111 to the last
examination on day 181. Prednisolone had been
maintained at a dose of 0.18 mg/kg q 24 h after day 181.
We followed up the clinical signs and measured serum
sodium, potassium and Na:K ratio, lastly on day 181
(20th August 2020), and no more DOCP was
administered after day 97 (Figure 1).

Sodium and potassium concentration (mmol/L) measured in the serum of the dog for 181 days. Day 0, the first visit; day 7,
ACTH stimulation test; day 14, 67, and 97 administered desoxycorticosterone pivalate (DOCP).

Results and Discussion
Desoxycorticosterone
pivalate
(DOCP) and
prednisolone were chosen for treating the clinical
abnormalities. We did not choose fludrocortisone for
sole prescription as DOCP is more convenient for
adjusting
mineralocorticoid
dosage
than
fludrocortisone and even fludrocortisone contains both

mineralocorticoid and glucocorticoid. The appropriate
dose of DOCP for treating this case was 1.5 mg/kg
subcutaneous injection every 28-30 days and the
injectable period could be adjusted followed by serum
potassium concentration (Sieber-Ruckstuhl et al., 2019).
Prednisolone 0.5 mg/kg PO q 12 h was prescribed as a
glucocorticoid supplement in the first week after we
discharged the dog and planned to taper the dose
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dependent upon clinical signs. After the first
administration of DOCP, we found only mild
hyponatremia for several weeks but the Na:K ratios
were between 36.2:1 to 43.0:1. These were from low
potassium levels suggested to be from DOCP
administration (Baumstark et al., 2014). We monitored
the dog every 4 weeks and found sodium, potassium
and Na:K ratios within normal limits after the last
administration of DOCP on day 91. Therefore, no
DOCP was administered on day 181, the last day of
examination. The dog had been well with only
prednisolone orally at a dose of 0.19 mg/ kg q 24 h. A
lower initial dose had made no difference in survival
or post-treatment serum sodium, potassium or Na:K
ratio compared to the recommended dose at 2.2 mg/kg
(Bates et al., 2013). Importantly, client education on the
perfect dose can change for any reason. We
recommended monitoring every 4 weeks.
Major abnormalities of the hypoadrenocorticism
dogs include hyponatremia, hyperkalemia, nonregenerative anemia and lymphocytosis (ScottMoncrieff, 2015). Nevertheless, these changes are not
present in all cases. Fewer clinical presentations can be
a significant diagnostic consideration. Complete blood
count, serum biochemistry and urinalysis are routine
diagnostic techniques. This dog was, however,
presented
without
any
indication
of
hypoadrenocorticism.
We
performed
routine
diagnostic techniques without measuring the
electrolytes at first. When we found azotemia with
non-specific
gastrointestinal
signs
and
hemoconcentration, we could have missed the clues
that this dog had hypoadrenocorticism if we had
decided not to evaluate serum electrolytes. Indeed,
electrolytes are essential diagnostic tools to expose
additional problems. Azotemia was resolved 24 hours
after fluid therapy. It was likely pre-renal azotemia
consequent upon hemoconcentration.
This
was
a
rare
case
that
found
hypoadrenocorticism in a French bulldog since the
predisposed breeds for the disease are mentioned
above. The prognosis for dogs with naturally occurring
hypoadrenocorticism is excellent. The average survival
time for treated dogs is 4.7 years and most of them die
from other health problems (Lathan and Thompson,
2018).
In conclusion, we suggest a serum electrolyte
technique should be preferred as one of the screening
tests in azotemia case with an unclear history since the
Na:K ratio is meaningful information for a diagnosis of
hypoadrenocorticism. The ACTH stimulation test is a
definitive diagnosis for suspected cases. A smaller than
recommended dose and lesser frequency of the DOCP
with prednisolone seemed adequate for controlling
clinical problems in the successful management of the
hypoadrenocorticism in a French Bulldog.

Acknowledgements
We thank the owner of the dog for allowing us to
share its details and staff at Prasu-arthorn Animal
Hospital, Faculty of Veterinary Science, Mahidol

University, Salaya, Phutthamonthon, Nakhon Pathom,
73170 Thailand.

References
Bates JA, Shott S and Schall WD 2013. Lower initial
dose desoxycorticosterone pivalate for treatment of
canine primary hypoadrenocorticism. Aust Vet J.
91(3): 77-82; discussion 81-72.
Baumstark ME, Sieber-Ruckstuhl NS, Muller C,
Wenger M, Boretti FS and Reusch CE 2014.
Evaluation of aldosterone concentrations in dogs
with hypoadrenocorticism. J Vet Intern Med. 28(1):
154-159.
Bellumori TP, Famula TR, Bannasch DL, Belanger JM
and Oberbauer AM 2013. Prevalence of inherited
disorders among mixed-breed and purebred dogs:
27,254 cases (1995–2010). Journal of the American
Veterinary Medical Association. 242(11): 1549-1555.
Lathan P and Thompson AL 2018. Management of
hypoadrenocorticism (Addison’s disease) in dogs.
Veterinary Medicine: Research and Reports. 9: 1-10.
Scott-Moncrieff
JC
2015.
Chapter
12
Hypoadrenocorticism. In: Canine and Feline
Endocrinology (Fourth Edition).
Edward C.
Feldman, Richard W. Nelson, Claudia E. Reusch,
and J. Catharine R. Scott-Moncrieff (eds). St. Louis:
W.B. Saunders. 485-520.
Seth M, Drobatz KJ, Church DB and Hess RS 2011.
White blood cell count and the sodium to
potassium ratio to screen for hypoadrenocorticism
in dogs. J Vet Intern Med. 25(6): 1351-1356.
Sieber-Ruckstuhl NS, Reusch CE, Hofer-Inteeworn N,
Kuemmerle-Fraune C, Muller C, HofmannLehmann R and Boretti FS 2019. Evaluation of a
low-dose desoxycorticosterone pivalate treatment
protocol for long-term management of dogs with
primary hypoadrenocorticism. J Vet Intern Med.
33(3): 1266-1271.

